Related Experiment Videos
Renal allograft function and cytomegaly
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association
|January 1, 1980
Summary
Cytomegalovirus infection and reduced azathioprine dosage after transplantation can impair kidney graft survival. However, reduced graft function in cytomegalovirus cases may not always indicate rejection.
Area of Science:
- Nephrology
- Immunology
- Transplantation Medicine
Background:
- Cytomegalovirus (CMV) infection is a significant complication in organ transplantation.
- Azathioprine is an immunosuppressive drug commonly used post-transplant.
- The impact of CMV infection and immunosuppression on graft outcomes requires further clarification.
Purpose of the Study:
- To investigate the relationship between cytomegalovirus (CMV) infection, azathioprine dosage, and kidney graft survival.
- To determine if reduced graft function during CMV infection is solely due to rejection.
Main Methods:
- Retrospective analysis of 20 seronegative and 61 seropositive first cadaver donor kidney graft recipients.
- Evaluation of graft survival rates in relation to CMV status and azathioprine treatment.
- Preliminary assessment using 125I-labelled fibrinogen uptake and graft morphology.
Main Results:
- Curtailment of azathioprine, CMV infection, or both were associated with graft rejection and reduced graft survival.
- Preliminary data suggested that impaired graft function in CMV cases is not always a result of rejection.
- Graft function depression might occur independently of rejection.
Conclusions:
- CMV infection and reduced azathioprine therapy are critical factors influencing kidney transplant outcomes.
- Reduced graft function in the context of CMV infection warrants careful evaluation to differentiate from rejection.
- Optimizing immunosuppression and managing CMV are crucial for improving graft survival.